semaglutide launch title Today we launch, Obeda®, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Alkem Launches India's First Single-Shot

(Novo Nordisk ended their savings program for Saxenda as of June 30, 2023.) Eli Lilly, the maker of Mounjaro, offers a similar savings card that can bring the cost down to as low as $25 for a monthly supply

Retatrutide, the triple-agonist GLP-1/GIP/glucagon receptor peptide, presents unique storage challenges that go beyond what most researchers expect

Keep right at the fork, follow signs for Chesebro Rd and merge onto Chesebro Rd

Most of my patients describe it as "just a quick pinch," and then it's over

By correcting conditions like megaloblastic anemia, these injections ensure your body has plenty of healthy red blood cells to carry oxygen where it needs to go

Glp1r Tie2/ mice were generated by crossing Glp1r fl/fl mice with Tg (Tek-Cre)1Ywa ( Tie2) Cre mice (Jackson Laboratory, 008863) to target endothelial and immune cells in the Tie2 domain, as previously described (25, 26)